Bio-Techne
$72.40Change from previous close: 0.00%
At a glance
- Revenue growth
- −0.38%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +147.77%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 15.0%
- FY to Jun 2025: 6.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 |
|---|---|---|---|---|---|
| Total assets | 2,587 | 2,558 | 2,704 | 2,639 | — |
| Current assets | 744 | 608 | 617 | 621 | — |
| Cash and equivalents | 265 | 162 | 152 | 181 | — |
| Short-term investments | — | 0.0 | 1.1 | 23.7 | 74.5 |
| Receivables | 217 | 207 | 241 | 218 | — |
| Inventory | 196 | 189 | 180 | 172 | — |
| Net property, plant and equipment | 299 | 319 | 342 | 325 | — |
| Goodwill | 975 | 981 | 973 | 873 | — |
| Other intangible assets | 303 | 366 | 507 | 535 | — |
| Long-term investments | 246 | 251 | 242 | 256 | — |
| Current liabilities | 164 | 176 | 159 | 129 | — |
| Accounts payable | 26.7 | 25.3 | 38.0 | 25.7 | — |
| Long-term debt | 200 | 346 | 319 | 350 | — |
| Total debt | 289 | 444 | 420 | 455 | — |
| Total liabilities | 479 | 639 | 635 | 672 | — |
| Total equity (incl. minority) | 2,108 | 1,919 | 2,069 | 1,967 | — |
| Retained earnings | 1,144 | 1,066 | 1,325 | 1,309 | — |
| Minority interest | — | 0.0 | 0.0 | 0.0 | -0.8 |